Navigation Links
Frost & Sullivan Recognizes Cardiocom as a Technology Enabler for Superior Cost-Effective Remote Chronic Care Management
Date:2/16/2011

MOUNTAIN VIEW, Calif., Jan. 10, 2011 /PRNewswire/ -- Based on its recent analysis of the remote patient monitoring market, Frost & Sullivan recognizes Cardiocom with the 2011 North American Frost & Sullivan Award for Enabling Technology. Cardiocom provides integrated clinical telehealth services that offer significant cost savings to the healthcare community.

(Logo:  http://photos.prnewswire.com/prnh/20081117/FSLOGO)

Cardiocom combines advanced telehealth technologies and expert nurse services enabling them to achieve a superior customer relationship and a competitive edge over other companies in the remote patient monitoring market.  "Products offered by Cardiocom include COMMANDER®, TELESCALE®, AUTOLINK®, GLUCOCOM® and OMNIVISOR®. All of these products utilize advanced connectivity solutions in both its hardware and software components," states Frost & Sullivan Research Analyst Arjunvasan Ambigapathy. "In addition, Cardiocom's Integrated Nurse Services Program, which is unique in the industry, provides a turn-key solution that comes with rapid ramp-up, predictable costs and proven outcomes."

The COMMANDER telemonitoring device is an integrated system that includes Cardiocom developed peripheral biometric devices to monitor weight, blood pressure, blood glucose, oxygen saturation and peak flow. It also features an intelligent clinical branching logic system that presents questions based on the patient's responses to previous ones.

The TELESCALE telemonitoring device is programmed to provide instant feedback to users based on the variance in daily patient weight. It includes an integrated messaging and weighing system along with waist-height patient interface that can weigh patients up to 500 lbs. with accuracy and consistency of +/-0.1 lb. Cardiocom's AUTOLINK device connects with GLUCOCOM, a proprietary blood glucose meter, to remotely measure blood glucose levels. All telemonitoring trended information is then accessed using the OMNIVISOR patient data management system.

Unlike other remote monitoring software products that merely report vital sign readings, Cardiocom's OMNIVISOR offers detailed analysis of patient data. In addition to high scalability of application, OMNIVISOR can exchange data with electronic medical records using certified industry standard interface methodologies.

"Cardiocom has implemented a comprehensive, analytical approach by incorporating advanced telehealth software algorithms and effective nurse service programs which provide cost benefits and efficiency in telehealth care to customers," says Ambigapathy.  He also notes, "Each Cardiocom call center nurse is capable of monitoring and coordinating care of 250+ patients, delivering a highly efficient service at a low cost.  Cardiocom provides a wide array of clinical management services including; identification, stratification, enrollment, intake assessment, health survey screening, coaching, intervention, high-risk management and outcome reporting. It provides timely interventions at the 'teachable moment' to reduce hospitalization and ER visits."

Adopting Cardiocom's range of solutions offers numerous benefits that create opportunities for accountable care organizations, medical homes, home health, health plans, hospitals, and specialty care organizations. Frost & Sullivan recognizes that Cardiocom periodically obtains feedback from customers, which forms a vital component for their strategic planning when developing or releasing a new product to the market, as one reason contributing to its innovation. Such an important activity creates an enhanced value for Cardiocom's customers.

Each year, Frost & Sullivan presents this award to the company that has developed a pioneering technology that not only enhances current products but also enables the development of newer products and applications. This award recognizes the high market acceptance potential of the recipient's technology.

Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

In summary, Cardiocom's products and solutions provide superior chronic care management by addressing the country's demand to manage heart failure, COPD, asthma, diabetes, hypertension, ESRD and other chronic conditions. Based on its industry achievements and superior performance in the area of telehealth, Cardiocom has been selected to receive the 2011 Frost & Sullivan Enabling Technology of the Year Award in the North American remote patient monitoring market.

About CardiocomCardiocom, the Experts in Telehealth is an award-winning leader in innovative home telehealth solutions. Founded in 1997, Cardiocom develops, manufactures and markets its own telehealth devices for heart failure, diabetes, hypertension, COPD, asthma, ESRD and other chronic conditions. Cardiocom's clients include some of the most respected health plans, hospitals, home health companies, physician groups, and coordinated care companies in the nation. Through these established relationships, Cardiocom improves the lives of thousands of people each day. For more information on Cardiocom and its services, call 888-243-8881 or visit http://www.cardiocom.com.  

About Frost & SullivanFrost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents. To join our Growth Partnership, please visit http://www.awards.frost.com.Contact:Jake Wengroff210.247.3806jake.wengroff@frost.com
'/>"/>

SOURCE Frost & Sullivan
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Frost & Sullivan Recognizes AOptix Technologies for its Pioneering Contribution to Security through Noninvasive Biometrics
2. Frost & Sullivan Recognizes Precise Biometrics as a Key Player in the Non-AFIS Fingerprint Market
3. Lockheed Martin Named Biometrics Company of the Year by Frost and Sullivan
4. Lockheed Martin Named Biometrics Company of the Year by Frost and Sullivan
5. RSA Designated as the Leader in One-Time Password Market by Frost & Sullivan
6. Frost & Sullivan Looks at Biometrics Advancement in Civil Security: Exploring Opportunities for Today and Beyond
7. Growing Demand for Rapid Screening and Detection Systems Pushes the European Maritime Security Market, Finds Frost & Sullivan
8. Frost & Sullivan: North American Government Biometrics Markets Thrive With Active R&D Thrust
9. Frost & Sullivan Recognizes MIRTEC With the 2009 Award for Automated Optical Inspection Product Innovation of the Year
10. ERGONEX Pharma receives Frost & Sullivans European Orphan Diseases Entrepreneurial Company Award 2009
11. Increased Spending on the EUs External Borders to Drive the Border Security Market, Says Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... 2016 http://www.researchandmarkets.com/research/5kvw8m/global_facial ) ... "Global Facial Recognition Market 2016-2020" report ... ) has announced the addition of the ... report to their offering. --> ... announced the addition of the "Global ...
(Date:2/4/2016)... -- The field of Human Microbiome research and ... hubs of the biotechnology industry. While the Human ... human microbiota, have garnered a lot of attention ... has literally exploded in terms of both basic ... on biomedical aspects of research, development, and commercial ...
(Date:2/3/2016)... --> --> Fourth quarter 2015:   ... compared with fourth quarter of 2014. Gross margin was 46% ... Earnings per share increased to SEK 6.39 (loss: 0.49). ... , --> --> January ... (233.6), up 1,142% compared with 2014. Gross margin was 43% ...
Breaking Biology News(10 mins):
(Date:2/5/2016)... -- On Thursday, February 11, 2-1-1 San Diego ... and disaster services, and the Community Information Exchange ... coordination and service delivery for the community to better ... better connect service providers to the information they can ... has handled more than 2.5 million connections ...
(Date:2/5/2016)... 5, 2016 Amarantus BioScience Holdings, ... focused on developing products for Regenerative Medicine, Neurology and ... Disease Designation (RPDD) from the US Food and Drug ... MANF was previously granted orphan drug designation (ODD) by ... Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), ...
(Date:2/5/2016)... Feb. 5, 2016 Australian-US drug discovery and development ... the appointment of a new Chairman, Mr John O,Connor ... effective immediately. James Garner , has also ... and former Acting CEO, Mr Iain Ross , will ... --> James Garner , has also been formally ...
(Date:2/4/2016)... San Francisco, CA (PRWEB) , ... February 04, ... ... future of enterprise talent development and compliance training, today announced an interactive ... on Morf Playbook™. The RAPS (Regulatory Affairs Professional Society) accredited interactive course ...
Breaking Biology Technology: